News & Updates

Show Multimedia Only

Romiplostim for chemo-induced thrombocytopenia delivers in phase 3 trial

04 May 2026 by

The thrombopoietin-receptor agonist romiplostim helps mitigate chemotherapy-induced thrombocytopenia, reducing related treatment modifications in patients with gastrointestinal cancers, as shown in the landmark phase III RECITE trial.

Romiplostim for chemo-induced thrombocytopenia delivers in phase 3 trial

04 May 2026

Does colonic anastomosis in CCUD lead to worse 30-day outcomes?

04 May 2026

The presence of a colonic anastomosis during colon conduit urinary diversion (CCUD) does not appear to result in poor outcomes within 30 days, according to a study. However, hypoalbuminemia may contribute to a higher likelihood of 30- to 90-day high-grade complications.

Does colonic anastomosis in CCUD lead to worse 30-day outcomes?

04 May 2026

Non-native English speakers at greater odds to do repeat colonoscopy

30 Apr 2026

Patients whose primary language is not English (NEPL) are more likely to have early repeat colonoscopy than those who are native English speakers (EPL), a study has found.

Non-native English speakers at greater odds to do repeat colonoscopy

30 Apr 2026

Reflux disease ups risk of colonic neoplasia

29 Apr 2026

The presence of reflux disease, no matter the type, appears to elevate the risk for colonic neoplasia, suggests a recent study.

Reflux disease ups risk of colonic neoplasia

29 Apr 2026

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

New drug applications approved by US FDA as of 16-31 March 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

Sulfur microbial diet ups CKD risk

28 Apr 2026

Adherence to sulfur microbial diet (SMD) appears to increase the risk of chronic kidney disease (CKD), irrespective of genetic risk, suggests a study.

Sulfur microbial diet ups CKD risk

28 Apr 2026

IRIS-guided visualization enhances postpyloric feeding-tube placement in critically ill patients

28 Apr 2026

Visualization technology guided by the integrated real-time imaging system (IRIS) results in a significant decrease in procedural duration and improvements in the first-attempt success rate for postpyloric feeding-tube placement in critically ill patients, according to a study.

IRIS-guided visualization enhances postpyloric feeding-tube placement in critically ill patients

28 Apr 2026

Low-FODMAP diet, rifaximin equally efficacious in IBS with diarrhoea

28 Apr 2026

In patients with diarrhoea-predominant inflammatory bowel disease (IBS-D), a low FODMAP diet (LFD) intervention and rifaximin treatment both result in improved outcomes, as shown in a study.

Low-FODMAP diet, rifaximin equally efficacious in IBS with diarrhoea

28 Apr 2026

Which nutrition support is best for ICU patients?

27 Apr 2026

The different types of nutrition support have varying effect on the nutritional status and clinical outcomes of critically ill patients in the intensive care unit (ICU), reports a study. However, parenteral nutrition (PN) combined with enteral nutrition (EN) appears to be most effective in improving clinical outcomes and nutrition support in these patients.

Which nutrition support is best for ICU patients?

27 Apr 2026

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

24 Apr 2026 by

Borderline personality disorder (BPD) is associated with higher risks of a wide range of physical diseases and increased mortality from all causes, natural causes, and external causes, according to a 16-year population-based cohort study in Hong Kong.

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

24 Apr 2026

News & Updates

Showing Gastroenterology articles

Showing

Specialty:

Romiplostim for chemo-induced thrombocytopenia delivers in phase 3 trial

Romiplostim for chemo-induced thrombocytopenia delivers in phase 3 trial

Does colonic anastomosis in CCUD lead to worse 30-day outcomes?

Does colonic anastomosis in CCUD lead to worse 30-day outcomes?

Non-native English speakers at greater odds to do repeat colonoscopy

Non-native English speakers at greater odds to do repeat colonoscopy

Reflux disease ups risk of colonic neoplasia

Reflux disease ups risk of colonic neoplasia

Original New Drug Application Approvals by US FDA (16-31 March 2026)

Original New Drug Application Approvals by US FDA (16-31 March 2026)

Sulfur microbial diet ups CKD risk

Sulfur microbial diet ups CKD risk

IRIS-guided visualization enhances postpyloric feeding-tube placement in critically ill patients

IRIS-guided visualization enhances postpyloric feeding-tube placement in critically ill patients

Low-FODMAP diet, rifaximin equally efficacious in IBS with diarrhoea

Low-FODMAP diet, rifaximin equally efficacious in IBS with diarrhoea

Which nutrition support is best for ICU patients?

Which nutrition support is best for ICU patients?

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality